Germany has not fully realised its biosimilar potential

29 September 2020 - Investigators have concluded that fully realizing the cost-saving potential of biosimilars could “release enormous resources” for ...

Read more →

U.S. hospitals turn down remdesivir, limit use to sickest COVID-19 patients

12 September 2020 - U.S. hospitals have turned down about a third of their allocated supplies of the COVID-19 drug remdesivir ...

Read more →

Three-quarters of New Zealanders intend to get COVID-19 vaccine

20 August 2020 - Three-quarters of New Zealanders say they would get the Covid-19 vaccine once it becomes available, new ...

Read more →

Irish pharmacists lobby for biosimilar substitution

17 August 2020 - Pharmacists in Ireland say the country is losing out on hundreds of millions of dollars in savings ...

Read more →

Disney official, others, talk about switch to biosimilars

12 August 2020 - Dismayed at the low biosimilar uptake and the lost savings, large employers are taking matters into their ...

Read more →

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

13 August 2020 - While the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect ...

Read more →

Slow start for infliximab biosimilars

3 August 2020 - Investigators speculate on why infliximab biosimilars don’t have a larger market share by now. ...

Read more →

Biosimilar insulin glargine on the PBS - information for health professionals and patients

27 July 2020 - Changes have been made from 1 July 2020 to the PBS listings for insulin glargine, as the ...

Read more →

Biosimilar Awareness Week proves successful for Australia

13 July 2020 - The Generic and Biosimilar Medicines Association in Australia reported its 2020 Biosimilar Awareness Week was successful, with ...

Read more →

Drug Utilisation Sub-Committee utilisation analysis public release documents

10 July 2020 - The utilisation analysis public release documents from the February 2020 Drug Utilisation Sub-Committee meeting are now available. ...

Read more →

Remove the disincentives and biosimilars will flourish, policy expert says

7 July 2020 - Patients could save as much as 17% on out-of-pocket costs if they used biosimilars, but many ...

Read more →

Use of infliximab biosimilar in Medicare population is low but growing

7 July 2020 - Slow growth of use of biosimilar infliximab in a Medicare fee-for-service population suggests lingering hesitancy on the ...

Read more →

Demand for dexamethasone soars after promising findings in UK

27June 2020 - Weekly demand in the U.S. is up more than 600%. ...

Read more →

The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany

15 June 2020 - Payers are increasingly calling for the value of new drugs to be measured explicitly.  ...

Read more →

Looking back, UK patients unhappy with adalimumab biosimilar switch

24 June 2020 - The UK results show how challenging switching to a biosimilar can be, according to patient groups. ...

Read more →